Convection Enhanced Delivery for Brain Drug Therapy
In our previous podcast on the blood brain barrier, we explored the issues and challenges involved with delivering therapeutic compounds into the brain. And while both big pharma and academic neuroscience continue to disregard the limiting factors of the blood brain barrier, a few pioneering companies are tackling this issue head on.
In this segment, we speak with Stephan Mittermeyer of BrainLAB, a medical equipment company headquartered in Munich, Germany. Stephan’s group has developed an integrated approach to circumventing the blood brain barrier that involves a process known as convection enhanced delivery, or CED. Join us as we explore BrainLAB’s innovative technique for delivering drugs directly into the brain – one that is as much a tale of physics and engineering as it is of biology.